Absci Corp is trading 10.0% up at $7.48 following a price-target hike from Guggenheim and a surge in broad risk-on market sentiment.
- Guggenheim raised its price target for Absci Corp to $15, signaling significant confidence in the stock's upside potential.
- The shares are also benefiting from a broad rally in growth and AI-related names as U.S. indices and futures climb.
- The move amplifies recent upside momentum for the company as investors pivot toward high-growth biotech and AI sectors.